Ultragenyx Pharmaceutical Inc.
GENE THERAPY CONSTRUCTS FOR TREATING WILSON DISEASE

Abstract:

This application relates to adeno-associated viral vectors encoding a truncated yet functional ATP7B for use in gene therapy for treating Wilson disease (WD). The truncated ATP7B described herein has several advantages over the wild-type ATP7B such as higher efficacy and improved manufacturing yield.